Journal articleJCO Clin Cancer Inform · January 2020
PURPOSE: More than 20% of US clinical trials fail to accrue sufficiently. Our purpose was to provide a benchmark for better understanding clinical trial enrollment feasibility and to assess relative levels of competition for patients by cancer diagnosis. M ...
Full textOpen AccessLink to itemCite
https://orcid.org/0000-0001-9866-4996